Search for: "Andersen v. Anderson"
Results 21 - 40
of 40
Sorted by Relevance
|
Sort by Date
17 Mar 2014, 8:05 am
The case, Lawson v. [read post]
19 Jul 2018, 10:59 am
Then, we had the big corporate meltdowns in the early 2000’s, Enron, Worldcom, Arthur Anderson, etc. [read post]
30 Oct 2013, 8:00 am
Trainmen v. [read post]
23 Nov 2012, 5:17 am
Wilkinson v London Strategic Health Authority is an interesting decision on the entitlement to copyright in training materials which has been sitting for too long in the IPKat's in-tray -- but you can read about it now thanks to Mark Anderson's to-the-point dissection of the issues on IP Draughts. [read post]
14 May 2014, 5:02 am
Anderson, 2011 U.S. [read post]
29 Jun 2010, 9:00 pm
Anderson (Houston, TX)Atlantic v. [read post]
6 Feb 2007, 10:53 am
Renewal By Anderson Corp., et al - "Issue. [read post]
11 Aug 2015, 1:44 pm
(The Supreme Court said, in D.C. v. [read post]
29 Mar 2008, 3:07 pm
Anderson", not to be confused with the Oregon "Atlantic v. [read post]
1 May 2024, 5:48 am
In United States v. [read post]
13 Dec 2006, 7:17 pm
Amodio, Kathy Amro, Ron Anastacio, Doug Ancil, Todd Andersen, Eric S. [read post]
28 Feb 2014, 11:03 am
It is actually surprising that we have not come all that far since the Arthur Anderson case, when the ABA held a conference with the description of one of the panels as: “Enron, Arthur Andersen, Sarbanes-Oxley, flash drives . . . all contribute to concern about what documents to create and retain. [read post]
22 Jun 2017, 4:39 pm
Andersen (here). [read post]
22 Jun 2017, 4:39 pm
Andersen (here). [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
3 Feb 2008, 10:20 pm
By doing so, SOX specifically addresses conflicts that arise when one professional entity performs work for a client but also owes fiduciary duties to the investing public and company shareholders. [28] SOX intimidated KPMG into disbanding their global legal entity, KLegal, which employed mover than 3,000 lawyers in 60 countries. [29] However, PriceWaterhouseCoopers, Deloitte & Touche, and Ernst & Young have no intentions of doing the same, despite added… [read post]
20 Sep 2014, 1:06 pm
(Pix (c) Larry Catá Backer 2014) Since 2010, I have been posting on the development of a new course I have been developing for our first year law school students, "Elements of Law. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
20 Mar 2023, 9:05 pm
But in a series of decisions, culminating in Kelly v. [read post]
1 Mar 2007, 4:57 am
OCs (Estimated Relative Risk or Odds Ratio with 95% CI) Bloemenkamp et al,[8]1995 Case-Control 2.2 (0.9-5.4) Spitzer (Transnational),[9] 1996 Case-Control 1.5 (1.1-2.2) Bloemankamp et al,[13] 1999 Case-Control 1.9 (0.8-4.5) Jick et al (UK-GPRD),[14] 2000 Cohort/Case-Control 1.9 (1.3-2.8)/2.3 (1.3-3.9) Farley et al (WHO),[6] 1995 Case-Control 2.4 (1.3-4.6) Jick et al (UK-GPRD),[7] 1995 Cohort/Case-Control 1.9 (1.1-3.2)/2.2 (1.0-4.7) Lidegaard et al,[12] 1998 Case-Control 1.44 (0.83-2.50)2.19… [read post]
